Neuromelanin in parkinsonian disorders: an update.

about

Cellular and Molecular Aspects of the β-N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy.[(18)F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP.

P2860

Q47260999-A77147B0-655F-4D18-BD78-1C258ED378DC Q47627080-13386CE0-F16D-4283-86A1-10CA39769DCD

P2860

Neuromelanin in parkinsonian disorders: an update.

Item

http://www.wikidata.org/entity/Q36359956

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Neuromelanin in parkinsonian disorders: an update.

@ast

Neuromelanin in parkinsonian disorders: an update.

@en

type

Item

label

Neuromelanin in parkinsonian disorders: an update.

@ast

Neuromelanin in parkinsonian disorders: an update.

@en

prefLabel

Neuromelanin in parkinsonian disorders: an update.

@ast

Neuromelanin in parkinsonian disorders: an update.

@en

P1476

Neuromelanin in parkinsonian disorders: an update.

@en

P2093

Paola Piccini

http://www.w3.org/2001/XMLSchema#string

Sara Pietracupa

http://www.w3.org/2001/XMLSchema#string

P2860

Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson??s disease

Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Ageing and Parkinson's disease: substantia nigra regional selectivity

Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease

Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies.

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure

Encapsulation of a reactive core in neuromelanin.

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging

P304

1116-1123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00207454.2017.1325883

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Martin-Bastida

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28460588

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

Neuromelanin in parkinsonian disorders: an update.

about

P2860

P2860

Neuromelanin in parkinsonian disorders: an update.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921